Date:1/26/2012

ancements and are priced at 40-60% less than the competition.  IFS provides superior value through its innovative set designs, use of standardized components and instruments across product lines, and our multiple distribution pathways.  IFS customers include ambulatory surgery centers, hospitals and orthopedic surgeons.  Please contact us for more information about our product and business model.This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events.  Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of Internal Fixation, such as whether we sell our new product offering  There are numerous risks and uncertainties that could cause actual results and Internal Fixation's plans and objectives to differ materially from those expressed in the forward-looking information, including whether Internal Fixation will have sufficient capital to continue its operations.
Actual results and future events could differ materially from those anticipated in such information.  These and all subsequent written and oral forward-looking information are based on estimates and views of  management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, IFS does not intend to update these forward-looking statements.For further information, please contact:

Laura Cattabriga, Chief Financial Officer

  

Tel: 786 268 0995

  

Laura.cattabriga@ifsusa.net

 

'/>"/>

SOURCE Internal Fixation Systems, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine technology :

1. Internal Fixation Systems Announces 510(k) Approval Granted by FDA for Subtalar Implants
2. JCM Passes Internal Quality Assessment for Azithromycin API Production
3. Internal and External Communication Insights: Effective Approaches for Reaching Clients and Co-Workers
4. Internal Fixation Systems, Inc. Announces Sale of Modular Locking Small Fragment System
5. Internal Fixation Systems, Inc. Announces DTC Eligibility
6. Internal Fixation Systems, Inc. Receives FDA 510(k) Clearance to Market Fixation Devices to Treat Bone Fractures and Osteotomies
7. Internal Groups are Valuable Sources for Pharmaceutical Competitive Intelligence Function
8. Building Support for a New Product Through Effective Internal Disease State Communication
9. Pharmaceutical Internal Communications Function Morphs to Address Corporate Priorities
10. Internal Fixation Systems, Inc. Announces Form S-1 Declared Effective by SEC and Anticipated Quotation for Trading on OTCQB
11. Maximizing the Potential of Internal and External Communications Groups